Hyperimmune plasma from convalescent antibodies
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hyperimmune plasma from convalescent antibodies, covering 2022-04-06 to 2022-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection [Phase 1, Phase 2]